Developer of nucleic acid diagnostics technology designed to identify microbial contaminants associated with the environmental and industrial sectors. The company's technology can detect legionella bacteria in the water which can lead to a life-threatening form of pneumonia, enabling pathology centers to have a novel and affordable testing alternative.
Developer of immuno-personalized diagnosis devices designed to detect bacterial and viral infections. The company's devices distinguish between bacterial and viral infections based on patients' immune responses to different infection types, enabling physicians to get rapid and actionable clinical information that guides them to make informed antibiotic treatment decisions.
Developer of diagnostic tests intended for clinical trials. disease diagnosis, and monitoring. The company's platform leverages sensitive and portable technology to detect and quantify biomarkers at extremely low concentrations, enabling healthcare professionals to make accurate and timely decisions.